Journal:JBSD:4
From Proteopedia
(Difference between revisions)

(Undo revision 1420057 by Alexander Berchansky (Talk)) |
|||
Line 5: | Line 5: | ||
<b>Molecular Tour</b><br> | <b>Molecular Tour</b><br> | ||
The key event in prion diseases is the conformational conversion from the cellular form of the prion protein (PrPC) to its pathogenic scrapie form PrPSc (or prion). PrPSc is the sole causative agent of prion diseases which self-propagates by converting PrPC to nascent PrPSc. Mutations in the open reading sequence of the prion protein gene can introduce changes in the protein structure and alter PrPSc formation and propagation, possibly by (de)stabilizing the physiological folding of PrPC and/or affecting its interactions with some yet unknown cellular factors. Some PrP polymorphisms may even inhibit the wild-type (WT) PrPC from being converted to PrPSc, with the so-called “dominant-negative” effect. | The key event in prion diseases is the conformational conversion from the cellular form of the prion protein (PrPC) to its pathogenic scrapie form PrPSc (or prion). PrPSc is the sole causative agent of prion diseases which self-propagates by converting PrPC to nascent PrPSc. Mutations in the open reading sequence of the prion protein gene can introduce changes in the protein structure and alter PrPSc formation and propagation, possibly by (de)stabilizing the physiological folding of PrPC and/or affecting its interactions with some yet unknown cellular factors. Some PrP polymorphisms may even inhibit the wild-type (WT) PrPC from being converted to PrPSc, with the so-called “dominant-negative” effect. | ||
- | Here we use molecular dynamics simulations to investigate the structural determinants of the globular domain in engineered Mouse (Mo) PrP variants, in WT human (Hu) PrP (PDB: 1HJN) and in WT MoPrP (PDB: 1XYX). The Mo PrP variants investigated here contain one or two residues from Homo sapiens and are denoted “MoPrP chimeras”. Some of them are resistant to PrPSc infection in | + | Here we use molecular dynamics simulations to investigate the structural determinants of the globular domain in engineered Mouse (Mo) PrP variants, in WT human (Hu) PrP (PDB: 1HJN) and in WT MoPrP (PDB: 1XYX). The Mo PrP variants investigated here contain one or two residues from Homo sapiens and are denoted “MoPrP chimeras”. Some of them are resistant to PrPSc infection in in vivo or in in vitro cell-culture experiments, the others are not. |
Our main results are the following: | Our main results are the following: | ||
(i) The chimeras resistant to PrPSc infection show shorter intramolecular distances between the α1 helix and N-terminal of α3 helix than HuPrP, MoPrP and the non-resistant chimeras. This is due to stronger specific interactions between these two regions, mainly the Y149-D202 and D202-Y157 (in Hu numbering and hereafter) hydrogen bonds and the R156-E196 salt bridge (Fig. 1). | (i) The chimeras resistant to PrPSc infection show shorter intramolecular distances between the α1 helix and N-terminal of α3 helix than HuPrP, MoPrP and the non-resistant chimeras. This is due to stronger specific interactions between these two regions, mainly the Y149-D202 and D202-Y157 (in Hu numbering and hereafter) hydrogen bonds and the R156-E196 salt bridge (Fig. 1). |
Revision as of 10:48, 23 July 2012
|
- ↑ REF
This page complements a publication in scientific journals and is one of the Proteopedia's Interactive 3D Complement pages. For aditional details please see I3DC.